India's Cipla Teams with Serum to Sell Vax in S. Africa

Source: Economic Times

Oct 13, 2015

Cipla Medpro has entered into an exclusive agreement with Serum Institute of India (SII) -- the world's largest vaccine manufacturer -- to supply vaccines to South Africa.

Medpro, which is Cipla's South African subsidiary, will be responsible for obtaining regulatory approvals and marketing of the vaccines under the deal terms. SII manufactures vaccines for various diseases including Polio, Diphtheria, Tetanus, Tuberculosis, Hep B, Measles, Mumps and Rubella.

Medpro CEO Paul Miller is hopeful that the agreement will not only enable affordable and accessible vaccines for South Africans, but also help Medpro become a significant player in the South African market.

Read the ET article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments